207 related articles for article (PubMed ID: 19038596)
1. Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications.
Goldsmith SJ; Vallabhajosula S
Semin Nucl Med; 2009 Jan; 39(1):2-10. PubMed ID: 19038596
[TBL] [Abstract][Full Text] [Related]
2. (68)Ga-radiopharmaceuticals for PET imaging of infection and inflammation.
Kumar V; Boddeti DK
Recent Results Cancer Res; 2013; 194():189-219. PubMed ID: 22918761
[TBL] [Abstract][Full Text] [Related]
3. Imaging of infection and inflammation with 18F-FDG-labeled leukocytes.
Rini JN; Palestro CJ
Q J Nucl Med Mol Imaging; 2006 Jun; 50(2):143-6. PubMed ID: 16770304
[TBL] [Abstract][Full Text] [Related]
4. Radiopharmaceuticals for scintigraphic imaging of infection and inflammation.
Boerman OC; Dams ET; Oyen WJ; Corstens FH; Storm G
Inflamm Res; 2001 Feb; 50(2):55-64. PubMed ID: 11289655
[TBL] [Abstract][Full Text] [Related]
5. Radiopharmaceuticals to image infection and inflammation.
Boerman OC; Rennen H; Oyen WJ; Corstens FH
Semin Nucl Med; 2001 Oct; 31(4):286-95. PubMed ID: 11710771
[TBL] [Abstract][Full Text] [Related]
6. Radiobelled white blood cells or FDG for imaging on inflammation and infection?
Signore A; Soroa VA; De Vries EF
Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):23-5. PubMed ID: 19182724
[No Abstract] [Full Text] [Related]
7. The role of nuclear medicine in imaging infection.
Auler MA; Bagg S; Gordon L
Semin Roentgenol; 2007 Apr; 42(2):117-21. PubMed ID: 17394924
[No Abstract] [Full Text] [Related]
8. Future diagnostic agents.
Gemmel F; Dumarey N; Welling M
Semin Nucl Med; 2009 Jan; 39(1):11-26. PubMed ID: 19038597
[TBL] [Abstract][Full Text] [Related]
9. Research Progress of [
Xu T; Chen Y
Mol Imaging Biol; 2020 Feb; 22(1):22-32. PubMed ID: 31076971
[TBL] [Abstract][Full Text] [Related]
10. The use of nuclear medicine in infections.
Peters AM
Br J Radiol; 1998 Mar; 71(843):252-61. PubMed ID: 9616233
[TBL] [Abstract][Full Text] [Related]
11. Radionuclide imaging of infection.
Love C; Palestro CJ
J Nucl Med Technol; 2004 Jun; 32(2):47-57; quiz 58-9. PubMed ID: 15175400
[TBL] [Abstract][Full Text] [Related]
12. Clinical role of anti-granulocyte MoAb versus radiolabeled white blood cells.
Ruf J; Oeser C; Amthauer H
Q J Nucl Med Mol Imaging; 2010 Dec; 54(6):599-616. PubMed ID: 21221068
[TBL] [Abstract][Full Text] [Related]
13. Pitfalls and Limitations of Radionuclide and Hybrid Imaging in Infection and Inflammation.
Glaudemans AW; Israel O; Slart RH
Semin Nucl Med; 2015 Nov; 45(6):500-12. PubMed ID: 26522392
[TBL] [Abstract][Full Text] [Related]
14. Nonspecific human immunoglobulin G for imaging infection and inflammation: what did we learn?
De Gersem R; Jamar F
Q J Nucl Med Mol Imaging; 2010 Dec; 54(6):617-28. PubMed ID: 21221069
[TBL] [Abstract][Full Text] [Related]
15. The uptake mechanisms of inflammation- and infection-localizing agents.
Oyen WJ; Boerman OC; van der Laken CJ; Claessens RA; van der Meer JW; Corstens FH
Eur J Nucl Med; 1996 Apr; 23(4):459-65. PubMed ID: 8612669
[TBL] [Abstract][Full Text] [Related]
16. Radiolabelled leukocytes for imaging inflammation: how radiochemistry affects clinical use.
Ballinger JR; Gnanasegaran G
Q J Nucl Med Mol Imaging; 2005 Dec; 49(4):308-18. PubMed ID: 16407814
[TBL] [Abstract][Full Text] [Related]
17. New imaging tools for the diagnosis of infection.
Walker RC; Jones-Jackson LB; Martin W; Habibian MR; Delbeke D
Future Microbiol; 2007 Oct; 2(5):527-54. PubMed ID: 17927475
[TBL] [Abstract][Full Text] [Related]
18. The role of nuclear medicine in infection and inflammation.
Becker W; Meller J
Lancet Infect Dis; 2001 Dec; 1(5):326-33. PubMed ID: 11871805
[TBL] [Abstract][Full Text] [Related]
19. Radionuclide imaging of nonosseous infection.
Palestro CJ; Torres MA
Q J Nucl Med; 1999 Mar; 43(1):46-60. PubMed ID: 10230281
[TBL] [Abstract][Full Text] [Related]
20. New concepts in infection/inflammation imaging.
Rennen HJ; Corstens FH; Oyen WJ; Boerman OC
Q J Nucl Med; 2001 Jun; 45(2):167-73. PubMed ID: 11476166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
